© 2020 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Opioids
FDA Updates: ALKS 3831 Wins Joint Panel Nod; Regeneron, Lilly Seek EUAs for Anti-COVID Antibodies
October 11, 2020
The PDUFA date for Alkermes' combination therapy is November 15, 2020.
The Financial Burden of the Opioid Epidemic
October 22, 2019
The opioid crisis cost the U.S. billions. Find out the impact on the future economy.
Surprising Findings About the Evolution of the Drug Epidemic
October 22, 2019
Despite the trust between physicians and patients, some physicians believe another prescription drug crisis may arise.
The Impact of Primary Care Appointment Times on Opioid Prescribing
October 15, 2019
A new study reveals that when physicians are under time constraints it can greatly impact their treatment decisions.
Missing Data Masks Scale of Opioid Epidemic
September 27, 2019
Study shows a significant portion of overdoses in the U.S. mortality data is missing information on specific drugs involved.
Study to Assess State Policies Governing Opioid Use and Pregnancy
September 25, 2019
Information gleaned will be crucial to providers, insurers, and policy makers.
Blue Cross NC Invests in Addiction Treatment Provider
September 06, 2019
Up to 15 clinics are set to open nationwide in the next year.
The Link Between Opioid Overdose and Household Prescriptions
August 12, 2019
Individuals without their own prescriptions may be at risk for overdose if they have access to family members’ drugs, according to a new study
New Report is Tackling Workplace Opioid Abuse
August 03, 2019
The first step to addressing opioid abuse for employers is to identify potential misuse and addiction.